Biolinq raises $100M to carry glucose sensor patch across the finish line
Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose biosensor-proceeds the company said would help set up its commercial | Biolinq’s coin-sized device, worn on the forearm, can also track sleep and activity data to help provide additional context around the user’s metabolic health.
Read More from the Global Wellness News ™